News and price dashboard

AxoGen jumps on beat and raised guidance

The biggest mover in the full-read items is AxoGen, up 20.53% in premarket trading to $45.15 from $37.46. Third-quarter adjusted EPS came in at $0.21 against a $0.13 estimate, with revenue of $75.8 million versus $73.16 million expected, up 26.2% from a year earlier. Breast reconstruction was the fastest-growing piece, with revenue in that segment up more than 60%, and Avance Nerve Graft made up 64% of revenue. Management raised full-year guidance to at least $290 million, or growth of at least 29%, with $283 million organic. The recently acquired BioCircuit brings NerveTape and should add at least $7 million in the fourth quarter and roughly $34 million in 2027 net of cannibalisation. Commercial payer coverage for Avance now reaches about 96% of US covered lives. Gross margin was 74.8%, down 180 basis points year on year on higher product costs but up sequentially from 72.7%.

Evercore's record quarter

Evercore rose 9.55% premarket to $284.68. Adjusted EPS of $4.28 beat the $2.53 estimate by 69%, and revenue of $1.17 billion came in 33% above the $878 million forecast. Adjusted net revenues were up 13% year on year at roughly $1.2 billion, a sixth consecutive quarterly record, with advisory fees of $1 billion. The compensation ratio fell to 63% from 65%, and the firm returned $189 million in the quarter, over $1 billion year to date. CEO John Weinberg pointed to record backlogs replenishing at a healthy rate; management also said non-M&A businesses now account for more than 40% of firmwide adjusted net revenues over the last four quarters. Note the stock had fallen 23% over the prior six months.

Beat-but-sold cluster: Blackbaud, V.F., Chefs' Warehouse

Three companies beat and still fell premarket, which is the clearest pattern in today's full reads. Blackbaud dropped 8.75% to $49 despite non-GAAP EPS of $1.36 against $1.33, because revenue of $292.64 million was essentially dead on the estimate; growth was 4.1%, free cash flow was $126 million, and the 2026 renewal cohort is about 40% larger than 2025's, which management said is weighing on reported growth into early 2027. V.F. Corp fell 3.82% to $16.38 after EPS of $0.70 against $0.53 and revenue of $2.7 billion against $2.66 billion, with gross margin up 290bp to 55.4%; Vans still fell 9.8% in the quarter and the company flagged $70 million to $80 million of unmitigated tariff costs in the second half. The Chefs' Warehouse fell 3.66% to $105 after EPS of $0.66 versus $0.58 and sales up 11.2% to $1.135 billion, with adjusted EBITDA up 26.3% and full-year guidance raised to $4.56–$4.61 billion in sales; the article notes the stock is up 86% over the past year on a P/E above 51.

GE Vernova orders and the Trench deal

GE Vernova beat on both lines, EPS $4.81 against $4.00 and revenue $12.64 billion against $12 billion, but shares rose only 0.55% premarket to $900. Orders nearly doubled, up 96% to $29.3 billion with book-to-bill above 2.0x, and backlog grew from $176 billion to about $200 billion. Free cash flow was $5.4 billion, up $4.7 billion year on year. Full-year guidance went up to $46.5–$47.5 billion revenue, 13.5–14.5% adjusted EBITDA margin and $16–$17 billion free cash flow, with Power margins hitting 21.4%. The company announced the Trench Group acquisition for its high-voltage grid business and doubled its buyback to $20 billion. Wind remains the soft spot. A separate headline-only slide deck item puts the Trench price at $9 billion.

European and Indian names

KPIT Technologies rose 3.87% to 552.5 on a quarter management called in line: revenue up 6.5% in rupee terms but roughly flat in constant currency, EBITDA margin up 60bp to 17.8%, product revenue up 25%, off-highway and commercial vehicles up 27%, passenger cars down 7%. Two large customers cutting or cancelling programmes cost the equivalent of 13% of sales, and margins are not expected back to 20–21% until early FY2028. KPN gained 2.87% to $4.199 on revenue of $1.5 billion against $1.47 billion expected, with group service revenue up 2.7% and EPS exactly in line; it reaffirmed its dividend and the EUR 250 million buyback. Epiroc went the other way, down 2.6% to $209.8 even with orders up 12% organically to SEK 17.5 billion and adjusted margin up to 20.4%, as operating cash flow fell to SEK 1.4 billion from SEK 2.5 billion on inventory build and long equipment lead times delay revenue conversion.

Smaller financials

OceanFirst posted core EPS of $0.48 against $0.40 and revenue of $185.13 million against $177.79 million in its first full quarter with Flushing Financial; net interest income rose to $172 million and core expenses of $114 million came in under the $120–125 million guide, though GAAP EPS was just $0.17 after $0.30 of merger costs. The stock barely moved. John Marshall Bancorp earned $0.55 against a $0.50 estimate on revenue of $18.06 million versus $18.61 million expected. HBT Financial declared a quarterly dividend of $0.25, payable 17 November to holders of record 9 November; the article notes the stock is up 55% over the past year near its 52-week high, and recent target raises from Keefe Bruyette & Woods to $43 and DA Davidson to $38.

What the headline-only items flag

A lot of this feed is routine Form 8K filings with no content behind them, plus a wall of TradingView chart posts. The headlines worth knowing about, without more detail than the headline gives: Boston Scientific fell 11% with a cybersecurity attack cited as weighing on guidance, Dropbox is cutting about 9% of its workforce with its CTO departing, LCI Industries confirmed an unsolicited non-binding $101-per-share cash proposal from Monomoy Capital Partners, and Artiva halted a cell therapy after patient deaths and cut 94% of staff. Robinhood fell on a Q3 miss with analyst target cuts, GSK dropped on weaker vaccine sales, and Sandoz cut its sales outlook. On earnings still to land, Alphabet and Microsoft report and the Fed decision is due. In the UK, Healey delivered his first budget, cutting the 2027 growth forecast to 1% and fiscal headroom to about £15 billion. Elsewhere: SK Hynix shares surged on a profit beat, Stellantis beat on revenue, EQT is acquiring Range, IREN secured $363 million of equipment financing, Scripps raised its political ad outlook while cutting 850 jobs, and the US goods trade deficit widened unexpectedly to $134.9 billion.

Visa beats but guides lower

The one piece of real depth in the feed is Visa's fiscal Q4. Adjusted EPS came in at $3.48 against a $3.44 consensus, and net revenue of $12.1 billion, up 13% year over year, matched expectations. The stock still fell 2.3% after hours, to $392.73 from a regular-session high of $403.51, because fiscal 2027 guidance calls for EPS growth in the low double digits to low teens, down from the 16% delivered in fiscal 2026. Payment volume growth also ticked down versus the prior quarter. Baird had flagged before the print that trimmed FY27 estimates could pressure a stock trading above its five-year average multiple; Susquehanna had gone the other way, lifting its target to $480 on Visa's positioning for agentic AI commerce. The board raised the quarterly dividend to $0.780. The article also notes two regulatory items sitting in the background: a potential £5 billion UK interchange lawsuit covering Visa and Mastercard, and lower small-merchant interchange rates that took effect in October 2026. Separately in the feed, headline-only posts quote Visa's CEO calling it "a milestone year" with record net revenue of $46 billion, up 15%.

After-hours earnings reactions

A large cluster of headline-only items covers the post-close tape. On the downside: CoStar down 12% despite topping Q3 estimates, Enphase down more than 10% on weaker-than-expected guidance and results, Seagate down 8% despite an earnings beat, NXP down 8% after reporting revenue of $3.8 billion up 19% year over year, Robinhood down 4% on a double miss, Sensata lower on weak Q4 revenue guidance, Landstar down 3% on a bottom-line miss tied to elevated claim costs, and Teradyne falling despite beating Q3 goals. On the upside: Ultra Clean up 11% on a Q3 beat and upbeat outlook, Manhattan Associates up 11% on an earnings beat, PPG up 7% on a beat-and-raise, and Logitech beating September-quarter views while guiding higher for the holiday period. These are headlines only, so I have the direction and in most cases the stated reason, nothing deeper.

Form 8-K wrapper filings

A long run of Form 8-K items from Investing.com UK carry no article body at all, just the filing notice and the ticker's move: Ultra Clean up 10.21%, Intapp down 8.91%, Senti Biosciences up 6.62%, Sensata up 4.01%, Slide Insurance down 2.37%, Waste Management down 2.16%, Enphase down 2.06%, Zillow Class C down 1.75%, Brightspire up 0.81%, Realty Income down 0.59%, F5 down 0.48%, ONEOK down 0.36%, Envista down 0.34% and STAG down 0.33%. There is nothing in the filings text to explain any of it, and more of the same appear headline-only for Welltower, O-I Glass, Charter, Logitech, Crane, Cooper, Arch Capital and a dozen small banks.

Quarterly misses with figures

Two smaller results were read in full. Renasant posted Q3 EPS of $0.86, eight cents below the $0.94 estimate, with revenue of $272.95 million against a $282.34 million consensus; the stock closed at $41.58, down 4.57% over three months and up 18.73% over twelve. O-I Glass reported a Q3 loss of $0.09 per share versus an expected $0.17 profit, a 26-cent miss, on revenue of $1.62 billion against $1.65 billion expected; shares closed at $6.43, down 46.73% over the past year, and the company had eight negative EPS revisions and no positive ones in the prior 90 days.

Air Canada ahead of results

Air Canada rose 2.0% to C$21.97. The article attributes it to positioning ahead of Q3 results due October 29, a published valuation note calling the stock roughly 7% undervalued at a C$23.09 fair value, and network news including new United Airlines routes, a Montréal-to-Seville service and Air Canada Cargo freighter routes to Panama City, Monterrey and Amsterdam. Scotiabank kept an Outperform rating while trimming its FY2026 EPS forecast; consensus is Moderate Buy with eight of eleven analysts positive and an average target of C$32.73. The TSX rose more than 100 points on base metals strength and Canada-US trade optimism.

Deals, management changes and index backdrop

Deal headlines include EnerSys acquiring Ultralife for $320 million in cash and UMB Financial acquiring El Dorado Savings Bank for $506 million. Langenberg upgraded Boeing on backlog strength, with separate headlines noting Boeing is oversold after a 10.69% drop. People moves run through the feed: Visteon's CFO departing, Eli Lilly reorganising its global operations and its international chief retiring, Elroy Air naming a CFO, and Cardiff Oncology naming an interim CMO. As market backdrop, the quote boxes in the read articles show the S&P 500 at 7,722.67 up 0.60%, the Nasdaq up 1.18%, the Dow up 0.03%, the FTSE 100 down 0.75% with HSBC off 5.42% after a Q3 miss and a $1 billion buyback, Brent around $109.70 and gold futures at $4,073.

The rest is noise

Beyond that, the bulk of the 200 items is filler: TradingView chart posts on gold, bitcoin, Tesla, USD/JPY and various crypto pairs, Nasdaq's automated oversold and moving-average alerts, two items literally titled "Test Funnel", and routine dividend declarations. Nothing there worth your time.

What's in the feed today

This is the unfiltered general wire on 27 October 2026, and most of it is bulk: SEC Form 8-K and Form 4 stubs with no text behind the headline, duplicate Investing.com UK and US versions of the same story, and a long run of TradingView chart posts. A handful of items were read in full and do carry real content, covered below. The common macro backdrop running through them is the Fed's 27-28 October meeting, with rates widely expected to be held, the S&P 500 up around 0.3%, the Nasdaq up about 0.5%, and VIX down roughly 3%. The FTSE 100 was the outlier, down about 1% with HSBC off 6.5% after a Q3 miss and Reckitt down 4.7%.

CoinShares buyback funded by selling its own crypto

CoinShares was the biggest single-stock move in the full-read set, up 5.3% in pre-open trade after its board activated a repurchase programme of up to $40 million. The board said Q3 2026 assets under management were broadly level with Q4 2025 and that buying back stock was a better use of capital than holding the equivalent digital assets, so it liquidated its entire corporate Ethereum treasury, around $16.6 million, and sold half its Solana holding, about $2.7 million, earlier in the month. Buying will be in the open market, possibly under Rule 10b5-1 plans, running until the next AGM expected in Q2 2027. The stock reached $3.99 against a 52-week high of $10.43. Separately the article notes CoinShares Digital Securities filed a new base prospectus for a secured debt programme covering its Bitcoin and Ethereum staking ETPs.

CoreWeave bounces off its 52-week low

CoreWeave rose 4.5% pre-open after announcing new compute capacity in Denmark and the launch of its first Global AI Network Backbone reaching into the Middle East and Asia Pacific. The piece frames this as the first company-specific good news after weeks of selling tied to the debt load, roughly $52 billion in total obligations with bond yields at record distressed levels earlier in the month. Two other supports are cited: Goldman Sachs had upgraded the stock to Buy from Neutral after the selloff, and Nvidia's CEO publicly called CoreWeave financially stronger with a falling cost of capital. The stock had bounced from a 52-week low of $51.24 and remains about 59% below its $141.79 high. Anthropic's IPO filing is mentioned repeatedly across the feed as a broader prop under AI infrastructure names.

Pentair beats and reaffirms

Pentair gained nearly 2.9% pre-open on Q3 adjusted EPS of $1.18 against $1.08 consensus, with revenue of $976 million versus $965.3 million expected. It reaffirmed full-year 2026 adjusted EPS of around $4.70 at the midpoint, above the $4.64 consensus, and guided Q4 to roughly $1.15 with sales growth of 7% to 9%. CEO John Stauch said execution improved with focus and urgency after a difficult second quarter in the Pool segment. The stock had been trading near its 52-week low of $51.13 going in.

CenterPoint raises guidance and its capital plan

CenterPoint reported adjusted EPS of $0.53 against $0.49 expected, with revenue of $2.12 billion exactly in line, and shares rose 1.67% premarket to $41.89. It lifted 2026 adjusted EPS guidance to $1.90-$1.92 and introduced 2027 guidance of $2.07-$2.09, both around 9% growth. The bigger item is a 10-year capital plan raised to $70.7 billion from $66.7 billion, with $1.5 billion of projects pulled into the first five years, which management says supports rate base growth above 14% through 2030. Higher financing costs cost $0.04 a share in the quarter, and the company expects to issue $500-700 million of equity in 2027. CEO Jason Wells pointed to customer-driven growth in Greater Houston as the driver. Adjusted FFO-to-debt was 13.7%, debt-to-equity 2.1, dividend yield 2.33% with 56 straight years of payments. There is a separate headline-only slide-deck item on the same $4 billion capital boost.

PrairieSky Royalty, strong quarter, flat stock

PrairieSky posted adjusted EPS of $0.36 against $0.3176 expected, a 13.4% beat, on revenue of CAD 165 million, of which CAD 153.4 million was royalty production revenue, up 42.3% year on year. Funds from operations rose 42% to CAD 127.9 million. Royalty production averaged 26,936 boe/d, up 5%, with realised oil just over CAD 100 a barrel. Net debt fell CAD 63.6 million in the quarter and CAD 153.5 million year to date. The shares barely moved, at $36.70, near the top of a $24.76-$37.30 range. CEO Andrew Phillips flagged Duvernay growth, with only 22 of 81 wells spudded this year producing at quarter-end, and expects Western Saskatchewan thermal leases to add 4,000-5,000 royalty barrels between 2030 and 2040. Q4 dividend set at CAD 0.265.

Dorman Products, tariff pricing bites the margin

Dorman beat on adjusted EPS at $2.08 versus $2.00 but missed on revenue at $561.7 million against $565.71 million. Sales were a record for the quarter, up about 3%, but EPS fell 21% from $2.62 a year earlier and adjusted gross margin dropped 500 basis points to 39.4%. Management attributed the comparison problem to last year's third quarter benefiting from tariff-driven price increases before the matching costs landed. Full-year guidance was narrowed to 2-3% sales growth and adjusted EPS of $8.50-$8.70, citing soft DIY demand and further tariff-related price cuts in Q4. The stock was essentially unchanged premarket at $124.70. Buybacks have run to a record $112 million in the first nine months.

Stephens trims Simpson Manufacturing

Stephens cut its Simpson Manufacturing price target to $205 from $215, keeping Equal Weight. Q3 beat on volume and operating leverage, with adjusted EBITDA margin of 26.2% against the firm's 23% estimate, but gross margin missed on higher raw material and freight costs. Simpson raised full-year operating margin guidance slightly, though the implied Q4 margin excluding a land sale moves lower on steel and freight costs, with price increases to be announced in coming weeks. Steel is over 50% above last year. Simpson also authorised a $1 billion open-ended buyback. Stephens' stated caution is a softer 2027 housing backdrop.

Form 8-K stubs with no content

A run of 8-K items carries only the filing headline plus a ticker move, no description of what was filed. For the record, the attached moves were Artiva Biotherapeutics down 31.01%, Envoy Medical down 8.15%, IP Strategy Holdings up 7.51%, Esquire Financial up 3.76%, Microbot Medical up 3.31%, GrabAGun up 2.44% and Itron up 0.09%. Nothing in the material explains any of these, so treat them as pointers to the filings rather than news. There is a separate headline saying IP Strategy Holdings regained Nasdaq compliance after a filing delay, which may or may not be the same event.

FX and commodity chart posts

Two FXCM technical posts were read in full and both are short setups: silver at four-hour timeframe with entry at 56.716, stop at 58.619 and target 53.094, and dollar-Swiss franc with entry 0.83360, stop 0.83947, target 0.82529. Both cite price below the Ichimoku cloud. These are third-party chart ideas, not analysis with an underlying event behind them. The feed carries a dozen more of the same type headline-only across gold, Nasdaq, Dow, bitcoin and various crosses.

The rest, headline-only

The remaining bulk is earnings headlines without text: Whirlpool missing and dropping premarket, ADNOC Drilling posting record Q3, Nokian Tyres, IndiaMART, Maruti Suzuki, Teknosa, Inderes, JSW Infrastructure, Daqo narrowing losses, Royal Caribbean raising full-year adjusted EPS guidance to $17.85-$17.95, TransUnion with 12% revenue growth. Several corporate actions: aTyr Pharma doing a 1-for-40 reverse split effective 28 October, WF Holding a 1-for-25, Rentokil a $200 million buyback, Arlo $100 million, Terrestrial Energy $25 million, Invesco a $1.5 billion term loan to repurchase preferred, General Motors moving its listing to Nasdaq on 17 November. A cluster of Cantor Fitzgerald reiterations across Faeth, Flagstar, Merck at $145 and Custom Truck, plus Argus downgrading Abbott on a guidance cut and raising Kinder Morgan. On macro, durable goods rose but missed forecasts, core capital goods rose in September, and Case-Shiller home prices came in at 2.7% year on year against 2.6% expected. On AI, headlines report AMD investing $1 billion in Meta's equity offering as part of a superintelligence infrastructure partnership and Nvidia committing $3 billion to the same Meta offering. A Reuters poll headline puts 2026 average gold at $4,495/oz and silver at $70.30/oz; UBS is reported raising its year-end Brent forecast to $110. None of these were read in full.

Celestica's blowout quarter and 2027 outlook

The biggest thing in the feed is Celestica, which rose nearly 9.7% in after-hours trading on third-quarter results that beat on every line. Adjusted EPS was $3.30 against $1.58 a year earlier, revenue $5.83 billion, up 83% year on year, both above the top of the company's own guidance, with adjusted operating margin at 8.5%, which CEO Rob Mionis called another new high. What really moved it was the forward guide: an initial 2027 outlook of $40.0 billion revenue, $21.50 adjusted EPS and a 9.0% operating margin, implying roughly 90% growth, plus a note that 2028 customer demand forecasts sit meaningfully above the 2027 revenue number. Q4 guidance is $6.275 to $6.575 billion revenue and $3.37 to $3.57 EPS, and full-year 2026 revenue was lifted to $21.0 billion from $20.5 billion with EPS to $11.55. The company also said it intends to start a new normal-course issuer bid buyback in Q4. The article notes the stock had been as much as 45% below its 52-week high of $474.025 going in, and that investor doubts about 800G and 1.6T networking programs versus customer concentration were largely what the print answered. Nothing in the broad market explained the move: the article describes the S&P, Dow and Nasdaq as essentially flat into the close.

Amkor rallies on a mixed print

Amkor Technology rose 5.1% after hours despite missing on both lines. Adjusted EPS was $0.76 against consensus near $0.77 to $0.78, revenue $1.99 billion versus roughly $2.03 to $2.04 billion expected. The offset was profitability: gross margin at 18.3% against 14.3% a year ago, operating income $225 million versus $159 million, with CEO Kevin Engel flagging record revenue in Computing and Automotive & Industrial while Communications stayed a drag. The piece also points to an expanded AI infrastructure partnership with NVIDIA announced days earlier, taking multi-year capacity commitments across Amkor's South Korea and Arizona plants to $3 billion, and notes the stock had already shed about 59% from its 52-week high. A separate headline-only item frames the same move as the stock rising 4% after hours.

Nucor meets consensus and slips

Nucor went the other way, down about 0.5% after hours to $256. Q3 diluted EPS was $5.80 on net sales of $11.25 billion, matching consensus almost exactly, and management guided Q4 earnings to be in line with or modestly above Q3, language the article reads as underwhelming given how the stock had run into the print. It opened at $262.13 and touched $262.86 before the release. Barclays had raised its target to $306 from $295 ahead of the report with an Overweight rating. The article also flags a trailing P/E near double the five-year median and net insider selling over the past year. A headline-only item adds that revenue topped estimates even as EPS met.

Whirlpool and the rest of the earnings tape

Whirlpool is covered only by headlines here, which say it missed by $1.25 with revenue short of estimates and the stock tumbled 8% on weak guidance and the Q3 miss. The rest of the earnings headlines split both ways: misses at Greenbrier (by $0.43), Sun (by $0.12), Capital Bancorp (by $0.03) and Alexandria Real Estate (by $3.70, though revenue topped), in-line results with soft revenue at Custom Truck One Source, and beats at Flexsteel, Hawkins (shares up 12%), Agilysys (which fell anyway despite raised guidance), Rambus (beat but fell on guidance), Brixmor, Northwest Bancshares, Simpson Manufacturing, Dorman and CB Financial. Cadence Design Systems is headlined as a beat-and-raise with the stock surging. JetBlue headlines conflict in tone: one says shares jumped on Q3 results and the 2027 outlook, another says it posted a wider loss on surging fuel costs. Public Storage missed Q3 estimates but raised its 2026 outlook.

Customers Bancorp at a 52-week low

Customers Bancorp hit a 52-week low of $20.45, on a 6.24% dividend yield, a 9.61 P/E and a beta of 1.53, with the one-year change still positive at 2.39%. The article gives no reason for the low and in fact recaps a strong Q3: EPS $2.25, up 10% sequentially, ROE 14%, net interest income over $208 million (up 8%), loans up nearly $500 million to $18.5 billion, deposits up 4% to a record $22.6 billion, margin at 3.19% with a September run rate near 3.25%, non-interest expense down to $113.4 million, and full-year guidance raised to 12%-plus loan and 9%-plus deposit growth. The bank also claimed AI tools cut loan underwriting cycle time by 95% and commercial deposit onboarding by over 90%.

Mostly filings and chart posts

A large share of the 200 items is regulatory boilerplate with no content behind the headline: Form 8-K notices for D.R. Horton, Nasdaq, Celestica, Amkor, Rambus, Whirlpool, AZZ, Clearwater Paper, C&F Financial, H2O America, NewHydrogen, Applied Materials, Cincinnati Financial, the three Gladstone entities and others, Form 144s for Euroseas and Symbotic, a run of Form 4 director filings at the New York Times, and routine insider sale disclosures at Goldman Sachs, MIAX, First Interstate and Beacon Financial. Alongside that sits a block of Nasdaq screen-generated "crosses critical technical indicator" and oversold alerts, and a long tail of TradingView chart ideas on gold, EURUSD, DXY, bitcoin, ETH and the indices. None of it carries substance worth pulling out.

Corporate and sector odds and ends

A few headline-only items are worth knowing exist: Intel is to acquire quantum computing software firm Classiq; Applied Materials is raising its Besi stake to roughly 20%; Bank of America, Blackstone, Citi and Morgan Stanley are reported arranging $63 billion of AI financing; Ben & Jerry's is said by the WSJ to be exploring a deal with a KKR executive to separate the brand from its owner; Truelink Capital is to acquire Johnson Controls' intrusion unit; and a US judge declined to block Eli Lilly's weight-loss drug ads, ruling against Novo Nordisk. On commodities, headlines report sugar, cocoa and coffee all falling on a decline in the Brazilian real, and natural gas at a new six-and-a-quarter-month low on warm forecasts. Two Reuters/Ipsos poll headlines carry Trump approval rising to 32% from a record low a week earlier, and Democrats leading Republicans 47% to 36% on the generic congressional ballot.

Anthropic IPO filing dominates the headline flow

The single biggest thread in the feed is Anthropic's IPO filing, carried mostly as a run of one-line newswire snaps. The company has filed to list Class A shares on the Nasdaq Global Select Market under the ticker ANT, with Goldman Sachs and Morgan Stanley named as leads, and one headline citing the WSJ says the offering is targeted for the week of November 16. The figures in the snaps: first-half 2026 revenue of $16.29 billion, up from $1.2 billion a year earlier. On the loss, the headlines conflict, one states a net loss of $80.7 million and another describes it as an $80.7 billion loss, so take that number as unresolved from what's here. Other snaps pull risk-factor language straight out of the filing: that revenue growth may not be sustainable and the rate of growth may decrease, that the company may need additional financing sooner than anticipated, that it does not expect to pay dividends, and unusually blunt language about advanced AI posing catastrophic or existential risks to humanity without appropriate oversight and about economic disruption greater than previous technologies. One headline puts planned compute spend at up to $120.5 billion across SpaceX, xAI and Nvidia. Separately, a headline says Meta plans to raise up to $95 billion in equity to fund AI.

Strive's $1bn preferred ATM

Strive (ASST) was the subject of two full reads of the same piece. The stock was down 2.5% pre-open after the bitcoin treasury company announced a $1.0 billion at-the-market program to sell its 15.00% Series A Perpetual SATS Preferred Stock. The article's argument is that an ATM lets Strive drip preferred into the market over time, which raises capital flexibly but leaves common holders under a growing layer of senior dividend claims that rank ahead of any buyback or distribution. Alongside that, Strive disclosed it bought 6,182 bitcoin for roughly $511 million between October 17 and 23, taking its treasury to around 43,000 BTC, financed through the same preferred machinery. StoneX raised its target on ASST to $43 from $32 the same day, keeping a Buy, which the piece credits with limiting the pre-market fall. The broader tape was no help or hindrance, S&P 500 up 0.3% and Nasdaq up 0.6%, so the move was read as company-specific. A separate headline covers the same offering. On the related theme, Strategy paused bitcoin purchases in the week of October 19-25, holding 848,517 BTC acquired for $64.02 billion at an average $75,446, and instead repurchased $204.9 million of its STRC preferred.

Corcept bounces on BELLA ovarian cancer data

Corcept (CORT) rose 3.7% pre-open after Part A of the Phase 2 BELLA trial of Lifyorli (relacorilant) with nab-paclitaxel and bevacizumab in platinum-resistant ovarian cancer. In 95 patients the triple combination showed median progression-free survival of 7.2 months and a 59% objective response rate, against 5.4 months and 37% for the two-drug arm in the Phase 3 ROSELLA study. In the roughly half of patients who were bevacizumab-naive, PFS was 8.1 months and response rate 66%. At six months, 88% of BELLA patients were alive, versus 82% for the two-drug arm and 77% for chemotherapy alone in ROSELLA, with median overall survival not yet reached. Context matters here: CORT had fallen about 29.6% between October 5 and October 23, including roughly 20% in one session on October 23 after Genmab said its Phase 3 RAINFOL-02 trial of rinatabart sesutecan hit both primary PFS and key overall survival endpoints in the same patient group.

Two Indian earnings calls, opposite stock reactions

Five-Star Business Finance reported Q2 FY27 net profit after tax of INR 299 crores, up 10% sequentially and 5% year on year, with record disbursements of INR 2,078 crores, up 39% sequentially and 74% year on year. AUM reached INR 14,640 crores, collection efficiency improved to 98.2% and credit cost eased to 1.80% of average AUM. The stock still fell 7.48% to $414.85. The article points to guidance for incremental borrowing costs rising to 8.70-8.75% in H2 and 10-15 basis points of spread compression as the likely concern, plus a high P/E relative to near-term growth; management is raising lending rates 1% on new disbursements from October to offset funding costs. More than 80% of AUM sits in three states. Mankind Pharma went the other way, up 3.83% to $2,302, on revenue of INR 4,338 crore (up 17.3%), EBITDA of INR 1,175 crore (up 27.2%, margin 27.1%) and PAT of INR 716 crore (up 37.7%). International revenue rose 33% to INR 680 crore and volume growth improved to 6.7% from 4.7% in Q1. Management kept FY27 EBITDA margin guidance at 25.5-26.5% despite beating it, and cut the consumer healthcare outlook to high single-digit growth.

Fair Isaac price target cuts after flat mortgage pricing

Mizuho cut Fair Isaac's target to $986 from $1,063, keeping Outperform, after FICO announced its Preferred Program on Friday, holding the wholesale mortgage score price at $10 through tri-merge resellers for lenders and brokers who opt in. The $10 covers a bundle of Classic FICO and FICO Score 10T, is flat year on year, and requires lenders to commit to pulling FICO scores, though it is not exclusive and lenders can still pull VantageScore. Mizuho trimmed revenue and adjusted EPS estimates on the flat 2027 pricing. The stock was at $815, down 52% year to date and 56% off its $1,859 high, with seven analysts cutting earnings estimates. The piece also recaps the cluster around it: Wells Fargo downgraded to Equal Weight, BMO cut to $897 (Outperform) and separately reiterated $1,150, UBS cut to $942 (Neutral), and RBC reiterated $1,525.

Other analyst notes, headline-only

A run of broker moves appears as headlines with no detail beyond the direction. Stephens raised targets on Zions Bancorp (capital strength), Horizon Bancorp (strong quarter), Banner to $78 (deposit growth) and South State (improved NIM outlook). Stifel went the other way across gambling and building names, cutting Rush Street Interactive on tax uncertainty, Flutter on the Brazil exit, Genius Sports on legal uncertainty, DraftKings to $32 on spending concerns, and Builders FirstSource. Morgan Stanley upgraded Lockheed Martin, saying the F-35 deal removes a key risk. UBS upgraded Ross Stores to Buy on a stronger sales outlook. Evercore has a preview out on Amazon ahead of Q3, and Citi named top picks in European energy services.

Brazil, oil and macro headlines

Brazil is the loudest macro item: headlines report Lula winning reelection, the real weakening 12%, Bovespa futures down nearly 20%, and analysts forecasting a market plunge. On oil, the FTSE piece in the feed attributes a rise to oil slipping on Iran de-escalation hopes, and a separate headline has Netanyahu's office denying reports of planned escalation against Iran before Israel's elections while Netanyahu touts a Trump endorsement and suggests they may restart the war. The IEA's Birol says energy prices won't return to pre-war levels in 2027, Russian refiners are reported ramping diesel output after a US deal, and Russian wheat export prices are down on Black Sea peace hopes. French 10-year yields dropped as much as 10.56bp to 4.9158%.

Corporate actions and company headlines

Getty Images filed for Chapter 11 with a $143.0 million DIP facility. Verizon reported Q3 and raised full-year guidance, though a separate headline notes the stock fell despite that. Ovintiv agreed to acquire Logan Energy for C$1.40 per share in cash, and a separate headline describes two top US natural gas producers combining in a $13 billion deal. Acuity is buying Parameter Technologies for $675 million, Francisco Partners closed its $650 million acquisition of Weave, Nathan's Famous completed its merger with Smithfield and delisted, and Boston Omaha closed the sale of its surety insurance unit for $84.3 million. Apollo is reported near a deal for roughly a 10% stake in Mubadala Capital. AutoZone's CFO Jamere Jackson departs November 25. LiveWire appointed a chief restructuring officer after its CEO resigned, which is the only colour behind its 8-K in the feed.

Routine 8-K filings with no content

Eight of the twenty full reads were Investing.com 8-K stubs for Peraso, GigCapital9, Boston Omaha, SS Innovations, SentinelOne, Empery Digital, LiveWire and Herc Holdings. They carry a ticker and a timestamp and nothing else, no description of what was filed. Worth knowing only as a prompt to go to the actual filing if any of those names matter to you.

TradingView retail setups

Five chart posts were read in full. UA_CAPITAL posted four near-identical long setups waiting on confirmation: CrowdStrike off a $234 demand zone with a descending trendline breakout needed, targets $287 and $300, invalidation below $220; Moderna at a $183 demand zone, targets $220, $254, $275, invalidation below $166; JPMorgan at $332, targets $353 and $365, invalidation below $324; Amazon at $248.50, target $278.50, invalidation below $238. A separate post from Danielroble5 describes buying Agnico Eagle and realising afterwards it had bought the Latin America-listed line rather than the US one. These are retail opinions, not research, and the rest of the TradingView items in the list are headline-only chart calls on gold, bitcoin, the dollar index and various FX crosses.

What this feed actually is

Two hundred items, and the honest summary is that very little of it is news. The bulk is SEC filing stubs with no transaction detail, retail chart posts from TradingView, and political social media. The twenty items read in full mostly confirmed that: the Investing.com filing pages carry nothing beyond their own title. The useful content came from the market snapshot embedded in those pages and from a handful of headline-only wire stories.

Market snapshot carried on the Investing.com pages

Every Investing.com page in the feed carries the same live sidebar, and it is more informative than the articles themselves. Dow Jones 52,215.16, down 1.23%, the weakest of the majors. S&P 500 7,623.68, off 0.52%. FTSE 100 10,690.36, down 0.32%, DAX down 0.75%, Nikkei down 0.34%. The standout in commodities is WTI crude, up 3.99% at 103.44, with Brent barely moved at 111.70 and up 0.18%, an unusually wide split. Gold futures 4,010.00, down 1.24%, silver down 1.90%, copper up 1.56%. Yields rose across the curve: US 10Y 4.988 and UK 10Y 5.3656, with the US 2Y up 1.01% on the day. On the UK board, Rolls-Royce was down 7.57% on 40.16m shares, IAG down 3.52%, HSBC down 1.07%, while BP rose 4.35% and Shell 3.72%, which fits the crude move. Among the broader losers listed, Intrum fell 36.21%, Petra Diamonds 26.14% and Volvo Car 24.30%. No article here explains any of those moves.

Headlines flagged on those same pages

The site's own "most popular" strip names the stories driving the day, and they are headline-only to me: a piece asking whether enough capital exists to finance everyone's AI spending plans, Trump saying there will be no strike on Iran today with a Qatari delegation in Tehran, Saudi Arabia's Tadawul closing down 2.65%, UAE closing more beaches over a Gulf oil spill, and Bitcoin steadying near $80,400 after a weekend selloff with a Fed decision ahead. The Iran and oil-spill items sit alongside that 3.99% WTI move, though nothing in the material connects them explicitly.

Insider filings with no content

A long run of filing stubs, all empty of detail. Pfizer alone accounts for six Form 4s dated 25 September, filed for directors Joseph Echevarria, Mortimer Buckley, James Quincey, Cyrus Taraporevala, Shantanu Narayen and James C. Smith, with the stock shown at minus 1.28%. UMH Properties has at least five, for Butewicz, Levy, Pruitt, CEO Samuel Landy and CFO Kevin Miller, all dated 15 September. Add Form 4s for Nike (shown at minus 2.66%), MongoDB (plus 2.44%), Invesco QQQ Trust and Global X Funds, and Form 144s for Stem and Medifast. A six-director Pfizer batch on one date is usually routine board compensation, but the filings in this feed carry no share counts or prices, so there is nothing to read into them from here.

TradingView retail chart posts

Roughly half the feed is TradingView, and much of it is one author, EhsanZeydabadi, posting the same template across crypto. The pattern in each: bearish 1H structure, but a bounce off support framed as a counter-trend long. Bitcoin, buy at 80,625, stop 80,251, targets up to 83,992, holding above the 79,800 support area. AVAX, buy 8.916, stop 8.787, targets to 10.307. BNB, buy 739.57, stop 736.02, targets 746.67 and 748.01, the only one described as already in short-term recovery. HBAR, buy 0.07713, stop 0.07648. NEAR, buy 4.554, stop 4.465, after a breakout above 4.503. All carry a 1% risk cap and TradingView's standard disclaimer. The rest of the TradingView mass is gold and FX chart calls, overwhelmingly bearish on XAUUSD, which at least rhymes with the 1.24% drop in gold futures.

Wire items worth knowing exist

Several headline-only pieces with real subjects: Oppenheimer sees the Q3 backdrop for web and commerce software improving while AI worries linger, Jefferies upgraded Dr. Reddy's on its margin outlook, Hassett said the US and Canada are "very close" to a trade deal, Britain will not join Canada's defence bank according to a source, and Zelenskiy said US warnings on ballistic strikes have fully resumed. Two OilPrice pieces, one on UK renewables hitting a grid bottleneck and one on the world tracking toward up to 2.8 degrees of warming. Transcript quotes posted to X have a Meta VP saying AI-assisted analytics is now over 70% of measured output versus effectively zero at the start of 2026, with software output per engineer more than doubled year on year, and a Blackstone COO noting BCRED took $1.4bn of net outflows as redemption requests exceeded quarterly limits, with gross sales near $750m against purchase requests at 10% of NAV versus a 5% limit. I have the headline framing on these, not the articles.

Political and social noise

The rest is campaign material with no market content: Trump posting a link to a Port Huron rally livestream, two longer Truth Social posts attacking a Michigan candidate and Fox News coverage, several White House posts, and Musk calling James Talarico a far-left extremist over a Daily Wire hidden-camera story. Nothing here touches a price.